David Cohen, regional director, northeast, for GE Real Estate's North America Lending Group says in a statement that GE expresses confidence in this portfolio for a number of reasons. The reasons are "class A assets, no rollover during the loan term, a class A location, strong creditworthy tenants, an experienced sponsor with local expertise and a robust suburban market that's very attractive to the life sciences industry."

The portfolio is made of three buildings--125 Spring St., 300 Patriot Way and 500 Patriot Way--sitting at the intersection of route 128 and route 2 here. The buildings comprise 278,904 sf on a 96.5-acre campus with two floors in 125 Spring St. and 300 Patriot Way and 500 Patriot Way each sporting three floors. The buildings are 89% leased, with only one of the properties not completely leased.

The largest of the two tenants is the Human Genetic Therapies division of Shire, a global specialty biopharmaceutical company. Shire will make the property its new headquarters, moving from nearby Cambridge.